X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
44
PharmaCompass offers a list of Cannabidiol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cannabidiol manufacturer or Cannabidiol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cannabidiol manufacturer or Cannabidiol supplier.
PharmaCompass also assists you with knowing the Cannabidiol API Price utilized in the formulation of products. Cannabidiol API Price is not always fixed or binding as the Cannabidiol Price is obtained through a variety of data sources. The Cannabidiol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cannabinoids manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cannabinoids, including repackagers and relabelers. The FDA regulates Cannabinoids manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cannabinoids API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cannabinoids manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cannabinoids supplier is an individual or a company that provides Cannabinoids active pharmaceutical ingredient (API) or Cannabinoids finished formulations upon request. The Cannabinoids suppliers may include Cannabinoids API manufacturers, exporters, distributors and traders.
click here to find a list of Cannabinoids suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cannabinoids DMF (Drug Master File) is a document detailing the whole manufacturing process of Cannabinoids active pharmaceutical ingredient (API) in detail. Different forms of Cannabinoids DMFs exist exist since differing nations have different regulations, such as Cannabinoids USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cannabinoids DMF submitted to regulatory agencies in the US is known as a USDMF. Cannabinoids USDMF includes data on Cannabinoids's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cannabinoids USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cannabinoids suppliers with USDMF on PharmaCompass.
A Cannabinoids written confirmation (Cannabinoids WC) is an official document issued by a regulatory agency to a Cannabinoids manufacturer, verifying that the manufacturing facility of a Cannabinoids active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cannabinoids APIs or Cannabinoids finished pharmaceutical products to another nation, regulatory agencies frequently require a Cannabinoids WC (written confirmation) as part of the regulatory process.
click here to find a list of Cannabinoids suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cannabinoids as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cannabinoids API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cannabinoids as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cannabinoids and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cannabinoids NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cannabinoids suppliers with NDC on PharmaCompass.
Cannabinoids Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cannabinoids GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cannabinoids GMP manufacturer or Cannabinoids GMP API supplier for your needs.
A Cannabinoids CoA (Certificate of Analysis) is a formal document that attests to Cannabinoids's compliance with Cannabinoids specifications and serves as a tool for batch-level quality control.
Cannabinoids CoA mostly includes findings from lab analyses of a specific batch. For each Cannabinoids CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cannabinoids may be tested according to a variety of international standards, such as European Pharmacopoeia (Cannabinoids EP), Cannabinoids JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cannabinoids USP).
Market Place
